All In Biotech

Drug Trial Radar · NCT00322907

Cotrifazid Safety and Efficacy Against Malaria

A Randomised Safety and Efficacy Trial of Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine+SP Against Resistant Malaria in Papua New Guinea

Last checked: Nov 20, 2026Latest source record: May 8, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 330 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

330

Actual

Start

Apr 2000

Primary completion

Not stated

Study completion Jan 2003

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Papua New Guinea Institute of Medical Research; Swiss Tropical & Public Health Institute
First posted
May 8, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to assess the safety and efficacy of Cotrifazid to treat uncomplicated resistant malaria and to compare the outcome with mefloquine or quinine+sulfadoxine/pyrimethamine (SP)

Conditions

  • Clinical Malaria

Interventions

  • Cotrifazid vs mefloquine or quinine+SPDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical treatment failure rate on day 14.
  2. Incidence of adverse events.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Health centers

    Madang and Maprik, Madang and East Sepik Province, Papua New Guinea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.